首页 | 官方网站   微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   22466篇
  免费   1876篇
  国内免费   33篇
医药卫生   24375篇
  2024年   37篇
  2023年   245篇
  2022年   387篇
  2021年   832篇
  2020年   522篇
  2019年   737篇
  2018年   808篇
  2017年   620篇
  2016年   700篇
  2015年   699篇
  2014年   863篇
  2013年   1307篇
  2012年   1896篇
  2011年   1825篇
  2010年   946篇
  2009年   816篇
  2008年   1321篇
  2007年   1379篇
  2006年   1254篇
  2005年   1186篇
  2004年   1097篇
  2003年   905篇
  2002年   891篇
  2001年   209篇
  2000年   211篇
  1999年   219篇
  1998年   175篇
  1997年   145篇
  1996年   124篇
  1995年   119篇
  1994年   96篇
  1993年   90篇
  1992年   131篇
  1991年   107篇
  1990年   104篇
  1989年   97篇
  1988年   115篇
  1987年   113篇
  1986年   99篇
  1985年   88篇
  1984年   105篇
  1983年   75篇
  1982年   63篇
  1981年   62篇
  1980年   41篇
  1979年   47篇
  1978年   49篇
  1975年   33篇
  1973年   31篇
  1970年   34篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
11.
12.
Surgery alone has long been the standard treatment for patients with operable non-small-cell lung cancer (NSCLC). However, despite complete resection, 5-year survival rates have been disappointing, with about 50% of patients eventually suffering relapse and death from disease. Randomized trials conducted in the 1980s hinted at a survival benefit for postoperative cisplatin-based regimens, but they were underpowered. A meta-analysis published in 1995 found a nonsignificant 13% reduction in the risk of death associated with cisplatin-based chemotherapy, with an increase of survival of 5% at 5 years. This led to renewed interest in adjuvant chemotherapy in resected NSCLC. Thousands of patients have been included in a new generation of randomized trials in the last 10 years. Most of these recent studies have now been reported and several have demonstrated a clear survival advantage for patients treated with platin-based adjuvant therapy. These results also suggest a greater benefit with modern two-drug regimens. In view of the most recent data, postoperative platin-based chemotherapy can now be considered the standard of care for completely resected NSCLC patients with good performance status.  相似文献   
13.
14.
ObjectivesTo evaluate and summarize the evidence linking balance impairment as a risk factor for falls in community-dwelling older adults.Study Design and SettingSystematic review and meta-analysis. English language articles in MEDLINE, EMBASE, CINAHL (1988–2009), under keywords of accidental falls, aged, risk factors, and hip, radius, ulna, and humerus fractures; and bibliographies of retrieved articles. Community-dwelling older adults in a prospective study, at least 1-year duration, age more than 60 years, and samples not specific to a single disease-defined population were included. Sample size, inclusion/exclusion criteria, demographics, clinical balance measurement scale, type of fall outcome, method of fall ascertainment, length of follow-up, and odds ratio (OR) or risk ratio (RR) were extracted. Studies must have reported adjustment for confounders. Random effects meta-analysis to generate summary risk estimate was used. A priori evaluation of sources of heterogeneity was performed.ResultsTwenty-three studies met the selection criteria. A single summary measure could not be calculated because of the nonequivalence of the OR and RR, producing an overall fall risk of RR of 1.42 (1.08, 1.85) and OR of 1.98 (1.60, 2.46).ConclusionsBalance impairment imparts a moderate increase on fall risk in community-dwelling older adults. The type of fall outcome, the length of follow-up, and the balance measurement tool impact the magnitude of the association. Specific balance measurement scales were identified with associations for an increased fall risk, but further research is required to refine recommendations for their use in clinical practice.  相似文献   
15.
16.
17.
18.
19.
20.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号